RxDoctor Payments Data

Jeffrey Findling, DPM

Podiatrist · Morgantown, WVNPI 1558685289

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Organogenesis Inc. at 26.0% of the total. 2025 is the largest year on record at $423, 2.2 times the $191 reported in 2019.

$1,684in general payments, 2019–2025

Across 94 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$438
  • Amgen$309
  • Abbott$254
  • Paratek Pharmaceuticals, Inc.$199
  • Smith+Nephew$169
  • Kowa Pharmaceuticals America, Inc.$57
  • plus $257 from 11 others

What the payments were for

  • Food & beverage$1,67299%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,684 in reported general payments places this provider in the 55th percentile of 37 podiatrist providers in West Virginia.

See all podiatrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$279,996
Medicare patients
691
Services billed
3,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Linezolid14$1,245
Ketoconazole27$1,052
Betamethasone Dipropionate12$446
Colchicine11$353
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$199
Mupirocin13$188
Terbinafine Hcl22$186
Clindamycin Hcl15$110
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$90
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$87
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$33
Meloxicam19$27

Paid to pharmacies, not to this prescriber.

Other podiatrist in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →